Loading...
REVERSE TYPE I INHIBITOR OF MYCOBACTERIUM TUBERCULOSIS CYP125A1
Cytochrome P450 CYP125A1 of Mycobacterium tuberculosis, a potential therapeutic target for tuberculosis in humans, initiates degradation of the aliphatic chain of host cholesterol and is essential for establishing M. tuberculosis infection in a mouse model of disease. We explored the interactions of...
Saved in:
| Main Authors: | , , , |
|---|---|
| Format: | Artigo |
| Language: | Inglês |
| Published: |
2010
|
| Subjects: | |
| Online Access: | https://ncbi.nlm.nih.gov/pmc/articles/PMC3011832/ https://ncbi.nlm.nih.gov/pubmed/21109436 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.bmcl.2010.11.007 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|